Perceptive Discovery, the preclinical and translational services division of Perceptive, today announced a $15M series of strategic investments to expand and enhance its radiochemistry, cell assays, ...
Surf Therapeutics, a clinical-stage neuro-immunomodulation company developing non-invasive ultrasound therapy for chronic inflammatory diseases, is announcing the start of an Early Feasibility Study ...
AZoLifeSciences on MSN
Turning human fat into insulin-producing organoids that reverse diabetes
By preserving fat tissue architecture, researchers created organoids that restore insulin function, paving the way for advancements in diabetes treatment.
The Vasco Translator Q1 is a purpose-built, stand-alone language device -- not just another app on your phone. It's ...
Preliminary Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth quarter-over-quarterPreliminary ending 2025 cash and cash ...
Non-dilutive public-private funded trial with NIAID STTR & Mary Gooze Clinical Trial and Translation AwardExpands iNKT platform into ...
Tech Xplore on MSN
New report highlights potential for AI to accelerate the real-world impact of research
A new report by HEPI and Taylor & Francis explores the potential of AI to advance translational research and accelerate the ...
Description: Biomechanics and biomaterials research stands at the forefront of contemporary bioengineering and biotechnology, shaping the future of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback